Analgesics & NSAIDs
Overview of Unit on Dosage Form and Medications
Introduction to the final unit on dosage forms in PharmOne: This unit focuses on the practical application of pharmacological knowledge, specifically exploring how medications are prepared and delivered to the body (dosage forms) and a comprehensive review of key drug classes. It serves as a culmination of previous learning, integrating drug mechanisms with patient care considerations.
Importance of study methods as students prepare for upcoming tests: Effective study strategies are crucial for retaining complex information. Students are encouraged to develop personalized study habits, such as active recall, spaced repetition, and practice questions, to solidify their understanding and prepare for both unit tests and the comprehensive final exam.
Study Resources
Availability of a chart for diuretics provided for students: A detailed chart illustrating various diuretic medications, including their mechanisms of action, primary indications, common adverse effects, and significant nursing considerations, has been distributed to aid in understanding this important drug class.
Recommendation to print and color code charts for enhanced study effectiveness: Visual aids, like color-coded charts, can significantly improve memory recall and understanding of complex drug information. Assigning specific colors to different drug classes, mechanisms, or adverse effects can create a more organized and memorable study tool.
Importance of consistent study habits to prepare for the final exam: Regular, spaced study sessions are more effective than cramming. Consistent review of material prevents information overload and allows for deeper understanding and better long-term retention of pharmacological concepts.
Topics covered include analgesics, antibiotics, and HIV antivirals: This unit will delve into the specific pharmacology, clinical uses, and nursing implications for these critical medication categories, covering their unique properties and patient management strategies.
Emphasis on not procrastinating and studying consistently: Timely and continuous engagement with the material is vital for success in this challenging unit, ensuring a thorough grasp of all topics before examinations.
Analgesics
Definition: Medications designed to relieve pain (analgesia) without inducing a loss of consciousness. They work by targeting specific pathways involved in pain perception, allowing patients to remain alert while experiencing reduced discomfort.
Analgesics block pain signals from nerves to the brain: Pain signals originate from nociceptors (pain receptors) at the site of injury or inflammation, travel along peripheral nerves to the spinal cord, and then ascend to the brain. Analgesics can intervene at various points along this pathway to reduce the perception of pain.
Types of analgesics discussed:
Opioids (narcotics): A class of drugs that act on opioid receptors in the brain, spinal cord, and other areas to produce profound pain relief. They are generally reserved for moderate to severe pain due to their potency and potential for adverse effects.
Adjunctive analgesic drugs: These are medications that are not primarily pain relievers but can enhance the effects of other analgesics or treat specific types of pain, such as neuropathic pain. Examples include antidepressants, anticonvulsants, corticosteroids, and muscle relaxants. They are often used in combination with opioids or non-opioids to achieve better pain control and reduce the required dose of primary analgesics.
Mechanism of Pain Perception
Pain is sensed when nerves send signals to the brain: Specialized sensory nerve endings, called nociceptors, detect noxious stimuli (e.g., tissue damage, extreme temperature, pressure) and convert these stimuli into electrical signals. These signals are transmitted via afferent nerve fibers (A-delta and C fibers) to the dorsal horn of the spinal cord, where they synapse with second-order neurons. These neurons then cross to the opposite side of the spinal cord and ascend through the spinothalamic tract to the thalamus, which acts as a relay station. From the thalamus, signals are sent to various areas of the cerebral cortex, including the somatosensory cortex, where pain is consciously perceived and localized, and to limbic areas, which are involved in the emotional response to pain.
Analgesics work by blocking these pain signals: Depending on their class, analgesics can act at different points:
Peripheral site: Some NSAIDs reduce prostaglandin synthesis at the site of injury, decreasing the sensitization of nociceptors.
Spinal cord: Opioids and some adjuncts can inhibit the release of neurotransmitters involved in pain transmission and hyperpolarize second-order neurons in the dorsal horn, preventing the ascent of pain signals.
Brain: Opioids modulate pain perception, emotional response to pain, and activate descending inhibitory pathways that reduce pain input at the spinal cord level.
Types of Pain
Acute Pain:
Characteristics: New, sudden onset, usually sharp, intense, and serves as a warning sign of tissue damage or disease. It is typically short-lived, resolving once the underlying cause is treated or healed. The duration is generally less than 3 to 6 months.
Example: Fractures, kidney stones, burns, postoperative pain, acute appendicitis, sprains.
Chronic Pain:
Characteristics: Persistent or recurrent pain lasting for more than 3 to 6 months, or beyond the expected period of healing. It often continues even after the original injury has healed and may not have a clear cause. Chronic pain can significantly impact a person's quality of life, leading to psychological, social, and functional impairments. It is frequently associated with depression, anxiety, and sleep disturbances.
Example: Arthritis (osteoarthritis, rheumatoid arthritis), fibromyalgia, neuropathic pain (e.g., diabetic neuropathy), chronic back pain, cancer pain, migraines.
Treatment of Pain
Stepwise approach to pain management based on severity: The World Health Organization (WHO) pain ladder provides a widely used framework for managing cancer pain, which can be adapted for general pain management. It recommends starting with the least potent medications and escalating treatment as needed:
Non-Opioid Analgesics (e.g., NSAIDs, acetaminophen/Tylenol) for mild to moderate pain: These are the first-line agents, suitable for pain levels rated out of .
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) include ibuprofen (e.g., Advil, Motrin) and aspirin. They possess analgesic, anti-inflammatory, and antipyretic properties by inhibiting cyclooxygenase (COX) enzymes.
Weak Opioids (e.g., Codeine, tramadol, hydrocodone in combination with acetaminophen/ibuprofen) for moderate pain: Used when non-opioids are insufficient. These are for pain levels rated out of . They are often used in combination with non-opioids to leverage synergistic effects and potentially reduce opioid dosage.
Examples: Morphine, Hydromorphone (Dilaudid), Oxycodone (OxyContin, Roxicodone), Fentanyl. These are used for pain levels rated out of .
Opioids
Classification of opioids:
Mild opioids: Such as Codeine and hydrocodone. These are typically used for moderate pain and are often found in combination with non-opioids to enhance efficacy. For example, hydrocodone is often combined with acetaminophen (e.g., Vicodin, Norco).
Strong opioids: Such as Morphine, fentanyl, hydromorphone, and oxycodone. These are indicated for severe pain due to their high potency and strong affinity for opioid receptors.
Note: Meperidine (Demerol) is not commonly used due to seizure risks: It produces a neurotoxic metabolite, normeperidine, which accumulates with repeated dosing, especially in patients with renal impairment or in the elderly, leading to CNS excitation manifested as tremors, muscle twitching, and seizures. It also has significant drug interactions and should generally be avoided for long-term pain management.
Indications for opioids include:
Treatment of severe pain postoperatively: Opioids are highly effective for acute, intense pain following surgical procedures, ensuring patient comfort and facilitating early mobilization and recovery.
Management of myocardial infarction pain: Morphine is particularly useful in acute MI as it reduces pain, decreases oxygen demand on the heart by venous vasodilation (preload reduction), and reduces anxiety.
Pain relief in cancer patients: Opioids are a cornerstone of pain management for moderate to severe cancer pain, including both acute exacerbations and chronic pain, often requiring individualized titrations to achieve effective control.
Acute trauma pain: For example, severe pain from fractures or major injuries.
Labor pains: In some cases, for severe pain during childbirth.
Contraindications and Cautions with Opioids
Do Not Give opioids to:
Patients with known drug allergies: A true opioid allergy (e.g., anaphylaxis, severe rash) warrants avoidance of that specific opioid and other opioids in the same chemical class.
Patients with severe respiratory issues (e.g., severe asthma, emphysema, sleep apnea): Opioids can significantly depress the respiratory drive, worsening hypoxemia and hypercapnia in patients with compromised lung function. Extreme caution is needed.
Patients with elevated intracranial pressure (ICP): Opioids can cause respiratory depression, leading to CO2 retention. Elevated CO2 levels induce cerebral vasodilation, which can further increase ICP and exacerbate neurological damage in conditions like head injury or brain tumors.
Infants and elderly who may have respiratory difficulties: Both populations are more sensitive to the respiratory depressant effects of opioids due to immature or age-related declines in physiological functions. Dosing must be carefully individualized and typically lower.
Patients with paralytic ileus: Opioids severely slow gastrointestinal motility, potentially leading to obstruction, abdominal distension, and exacerbation of paralytic ileus.
Pregnant patients due to potential effects on the fetus: Chronic opioid use during pregnancy can lead to neonatal abstinence syndrome (NAS) in the newborn, characterized by withdrawal symptoms such as irritability, tremors, vomiting, and seizures. Opioids can also cause respiratory depression in the neonate if given close to delivery.
Patients concurrently taking other CNS depressants (e.g., benzodiazepines, alcohol): This combination synergistically increases the risk of severe respiratory depression, profound sedation, coma, and death.
Adverse Effects of Opioids
Common Effects: These are dose-dependent and vary among individuals. Tolerance can develop to some side effects but typically not to constipation.
CNS depression: Ranging from drowsiness, sedation, confusion, to profound somnolence, and ultimately coma.
Respiratory depression: The most serious adverse effect, characterized by decreased respiratory rate ( <12 breaths/min), shallow breathing, and reduced tidal volume. This is the primary cause of opioid-related deaths.
Nausea and vomiting: Common, especially with initial dosing or ambulation, due to activation of the chemoreceptor trigger zone in the brainstem.
Urinary retention: Opioids increase bladder sphincter tone and decrease detrusor muscle contractility, making urination difficult.
Diaphoresis (sweating) and flushing: Due to histamine release.
Pupil constriction (miosis): A classic sign of opioid effect, often described as 'pinpoint pupils'.
Constipation: An almost universal effect due to decreased gastrointestinal motility. It requires proactive management (e.g., stool softeners, laxatives).
Itching (pruritus): Caused by histamine release, often managed with antihistamines.
Orthostatic hypotension: Peripheral vasodilation and blunting of baroreflexes can lead to a drop in blood pressure upon standing, increasing the risk of falls.
Critical Note: Always check respiratory rate before administering opioids. If the respiratory rate is below breaths per minute, hold the dose and notify the prescribing healthcare provider immediately, as administering the opioid could lead to life-threatening respiratory depression.
Overdose Management: Narcan (naloxone) is an opioid antagonist used for opioid overdose. Naloxone rapidly reverses the effects of opioids by competitively binding to opioid receptors with a higher affinity than the opioid itself, displacing the opioid and restoring normal respiratory function. Its onset is rapid (within minutes).
Acetaminophen (Tylenol)
Indicated for mild to moderate pain ( on a -point scale) and is an effective antipyretic (fever reducing) by acting on the hypothalamus to dissipate heat.
Cannot treat inflammation: Unlike NSAIDs, acetaminophen lacks significant anti-inflammatory properties, making it unsuitable for conditions primarily driven by inflammation, such as arthritis with prominent swelling.
Maximum daily dose:
mg/day for adults: For healthy adults with normal liver function, this is the generally accepted maximum to prevent hepatotoxicity.
mg/day for elderly or patients with liver impairment/alcoholism: Reduced doses are crucial for these populations due to decreased hepatic metabolic capacity and increased susceptibility to liver damage.
Toxicity can lead to hepatotoxicity (liver damage) and renal problems: Overdose of acetaminophen depletes liver glutathione stores, leading to the accumulation of a toxic metabolite (NAPQI) that causes hepatocellular necrosis. If severe, it can result in acute liver failure. Renal tubular necrosis can also occur.
Antidote for overdose is acetylcysteine: Acetylcysteine (Mucomyst, Acetadote) works by replenishing hepatic glutathione stores, which helps detoxify the toxic NAPQI metabolite, thereby preventing or minimizing liver damage. It is most effective when administered within 8-10 hours of overdose.
Tramadol
A mild to moderate pain reliever, similar in efficacy to some opioids but generally considered less potent than strong opioids. Its mechanism of action is dual: it is a weak opioid agonist (primarily targeting mu-opioid receptors), and it also inhibits the reuptake of norepinephrine and serotonin, which contributes to its analgesic effects, particularly in neuropathic pain. It is classified as a Schedule IV controlled substance due to its potential for abuse and dependence.
Precautions: Can lower the seizure threshold, especially at higher doses or in patients predisposed to seizures. Also has a risk of serotonin syndrome if combined with other serotonergic drugs (e.g., SSRIs).
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)
Mechanisms: NSAIDs exert their effects by inhibiting the cyclooxygenase (COX) enzymes, which are responsible for the synthesis of prostaglandins from arachidonic acid. Prostaglandins play roles in pain, inflammation, fever, and gastric protection.
Analgesic: By inhibiting prostaglandin synthesis at peripheral nerve endings, reducing pain sensitization.
Anti-inflammatory: By reducing prostaglandin-mediated inflammation (e.g., vasodilation, edema).
Antipyretic: By inhibiting prostaglandin synthesis in the hypothalamus, which helps reset the body's thermostat during fever.
Antiplatelet (Aspirin primarily): Aspirin irreversibly inhibits COX-1 in platelets, preventing thromboxane A2 formation and thus platelet aggregation.
Common NSAIDs include:
Ibuprofen (e.g., Advil, Motrin), naproxen (e.g., Aleve, Naprosyn), meloxicam (Mobic), celecoxib (Celebrex; a COX-2 selective inhibitor).
Adverse effects include:
GI upset, heartburn, potentially severe ulcers due to COX-1 inhibition: COX-1 produces protective prostaglandins in the gastric mucosa. Inhibition of COX-1 reduces this protection, leading to increased acid secretion, decreased mucus production, and reduced blood flow, making the stomach lining vulnerable to damage.
Renal impairment if used long-term or in kidney-compromised patients: Prostaglandins play a role in maintaining renal blood flow, especially in conditions of hypovolemia or existing renal dysfunction. NSAID inhibition of these prostaglandins can lead to acute kidney injury, particularly in dehydrated or elderly patients.
Increased risk of bleeding: Due to inhibition of platelet aggregation (more pronounced with non-selective NSAIDs and aspirin).
Black Box Warning: Risk of MI and stroke associated with NSAID use, particularly with prolonged use and higher doses: Non-aspirin NSAIDs (especially COX-2 selective inhibitors) can increase the risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke. This is thought to be due to an imbalance between prostacyclin (a vasodilator and antiplatelet agent produced by COX-2) and thromboxane A2 (a vasoconstrictor and pro-platelet aggregating agent produced by COX-1) favoring thrombus formation.
Aspirin
Different from other NSAIDs due to its irreversible antiplatelet actions: Aspirin acetylates and irreversibly inhibits COX-1, particularly in platelets. Because platelets lack a nucleus, they cannot synthesize new COX-1 enzymes, so the antiplatelet effect lasts for the lifetime of the platelet (7-10 days).
Contraindicated in children with viral illnesses (especially influenza or varicella/chickenpox) due to the risk of Reye’s syndrome: Reye's syndrome is a rare but severe condition causing swelling in the brain and liver, leading to encephalopathy, liver failure, and potentially death. Due to this risk, acetaminophen or ibuprofen are preferred antipyretics and analgesics in pediatric patients with viral infections.
Typically given for cardiovascular protection (e.g., low-dose mg/day) and pain in coronary artery disease (CAD): Its antiplatelet effect is crucial in preventing blood clot formation in patients at risk for or with established cardiovascular disease, reducing the incidence of MI and stroke. It can also be used for acute pain and fever, but its antiplatelet effect is the primary reason for its widespread use in CAD prophylaxis.
Nursing Implications
Collect thorough patient history: This includes current and past medical conditions, medication allergies (especially to NSAIDs or opioids), current medications (including over-the-counter drugs, herbal supplements), alcohol and substance use history, and previous responses to pain medications. This helps in selecting appropriate analgesics and identifying potential adverse reactions or interactions.
Monitor vital signs frequently: Especially respiratory rate (before and after opioid administration), blood pressure (for orthostatic hypotension with opioids), and pulse. Significant changes indicate potential adverse effects or inadequate pain control.
Assess pain regularly using a consistent pain scale (e.g., numeric rating scale) and characteristics (PQRST - Provoking factors, Quality, Region/Radiation, Severity, Timing). Ongoing assessment helps determine the effectiveness of interventions and adjust treatment as needed.
Educate patients on medication use and potential side effects: Provide clear instructions on dosage, frequency, maximum daily doses, how to take the medication (e.g., with food for NSAIDs), what side effects to watch for (e.g., drowsiness, constipation), and when to call the healthcare provider. Emphasize not combining multiple products containing acetaminophen or NSAIDs unwittingly.
Administer medications considering patient safety and individual health conditions: Adhere to the 'five rights' of medication administration. Adjust doses or choose alternative medications based on age, renal/hepatic function, concurrent diseases, and other medications to minimize risks.
Encourage non-pharmacological pain relief methods when possible: These can complement pharmacological treatments and reduce reliance on medications. Examples include heat/cold therapy, massage, repositioning, distraction techniques (e.g., music, TV), relaxation exercises, acupuncture, and physical therapy.
Monitor patients for signs of overdose, especially respiratory depression (e.g., decreased respiratory rate, shallow breathing, somnolence, pinpoint pupils) with opioids, and hepatotoxicity with acetaminophen (e.g., jaundice, nausea, dark urine, abdominal pain). Have reversal agents like naloxone readily available for opioid overdose.